Skip to main content

This job has expired

Director, Clinical Pharmacology Leader- Oncology

Employer
Bayer U.S.
Location
Whippany, New Jersey. Cambridge, Massachusetts
Salary
Full Benefits + Bonus
Closing date
Jun 30, 2019

View more

Job Details

YOUR TASKS AND RESPONSIBILITIES

 

The primary responsibilities of this role, Director, Clinical Pharmacology Lead, are to:

 

  • Independently represent Clinical Pharmacology (CP) Oncology in global project teams (GPTs) and related clinical teams;
  • Take over leadership activities from the Head of CP Oncology for specific assigned tasks, as appropriate;
  • Ensure adequate consideration and implementation of all aspects of CP, Pharmacokinetics (PK) and Pharmacokinetics / Pharmacodynamics (PK/PD) including model-based development approaches for all phases of Oncology drug development projects;
  • Set-up, execute and coordinate the CP strategy including related core CP studies in line with the overall development and submission strategy for assigned projects;
  • Drive quantitative PK/PD activities to support clinical study design and dose/schedule selection for First in Human (FiH) first-in-human and other exploratory clinical studies in close alignment with other functions within Translational Medicine Oncology (TMO), Oncology Development as well as Pharmacology, Toxicology, DMPK and Pharmacometrics;
  • Provide in-depth CP, PK and PK/PD advise and expertise to independently design, plan, execute and evaluate core CP studies as well as to adequately support relevant Oncology Development and Global Medical Affairs (GMA) studies with CP components such as dosing strategies, drug- interaction potential and exposure-response/safety analysis in close collaboration with the respective clinical functions and study teams;
  • Closely interact with other functions within Translational Medicine Oncology (TMO) as well as within Oncology Development to define the best use of biomarker concepts in conjunction with modelling and simulation approaches for development projects;
  • Independently evaluate and report CP related results, draw consequences from critical outcomes, adapt the project plan by implementing appropriate measures to avert risks in the context of the drug development project;
  • Constantly look for innovative approaches in the field of CP and ensure optimal utilization of resources and appropriate strategies to make go/no go decisions on programs in a timely and cost effective way;
  • Lead and manage the preparation of the CP sections of major clinical and regulatory documents (e.g. Common Technical Documents (CTDs), New Drug Applications (NDAs), Investigational New Drugs (INDs), Investigational Medicinal Product Dossiers (IMPDs) and provide global CP submission support for all countries / regions including the US, Europe, Japan, Asia Pacific, Canada and Latin America;
  • Represent CP Oncology externally, e.g. in meetings with authorities or key opinion leader (KOL) meetings and develop and manage KOL relationships to facilitate CP strategies as part of the overall development strategies;
  • Participate in critical in-licensing and out-licensing activities and independently provide CP, PK and PK/PD expertise in due diligences.

 

WHO YOU ARE

 

Your success will be driven by your demonstration of our LIFE values. More specifically related to this position, Bayer seeks an incumbent who possesses the following:

 

Required Qualifications:

 

  • Ph.D., M.D. or Pharm.D. with at least ten years’ extensive and profound expertise in the area of Clinical Pharmacology and Oncology Drug Development. Of this, at least six years of experience must be in Pharmaceutical industry or equivalent (e.g. Food & Drug Administration (FDA);
  • Strong background and demonstrated expertise in Clinical Pharmacology, PK and PK/PD including model-based drug development as evidenced by major Regulatory submission experience (e.g. NDAs, CTDs, INDs), scientific publications and presentations at major meetings;
  • Industry experience in applications of Basic Research and/or Clinical Research with the ability to translate preclinical projects to the clinic;
  • Proven ability to manage strategic, scientific and operational aspects of development projects from a Clinical Pharmacology perspective;
  • Evidence for leadership skills to direct and steer a team of experts, awareness of responsibility, efficient analytical thinking and working methods;
  • Capable of working self-dependently and on own initiative, excellent communication and organizational skills;
  • Ability to handle conflict and be highly resilient;
  • Very good knowledge of written and spoken English.

 

Preferred Qualifications:

  • Command of a second major language.

Bayer offers a wide variety of competitive compensation and benefits programs. If you meet the requirements of this unique opportunity, and you have the "Passion to Innovate" and the "Power to Change", we encourage you to apply now. To all recruitment agencies: Bayer does not accept unsolicited third party resumes.

Bayer is an Equal Opportunity Employer/Disabled/Veterans

   

Bayer is committed to providing access and reasonable accommodations in its application process for individuals with disabilities and encourages applicants with disabilities to request any needed accommodation(s) using the contact information below.    

Location: United States : Massachusetts : Cambridge || United States : New Jersey : Whippany     

Division: Pharmaceuticals    

Reference Code: 33949     

Contact Us

 

+ 1 888-473-1001, option #5

Company

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At Bayer you have the opportunity to be part of a culture where we value the passion of our employees to innovate and give them the power to change.

The Oncology Strategic Business Unit within the Pharmaceuticals Division of Bayer integrates key strategic and select operations functions from Drug Discovery, Development, Medical Affairs, and Strategic Marketing including Market Access.

The Strategic Business Unit enables the company to strategically manage and deliver upon it’s growing oncology portfolio, as well as its early –and late-stage development candidates, with a focused and integrated approach in a highly competitive and rapidly evolving environment.  The unit’s operating model will especially support accelerated development of potential therapeutic options for patients to fight cancer.

Company info
Website

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert